Combined biomarkers discriminate a low likelihood of bacterial infection among surgical intensive care unit patients with suspected sepsis.
about
Diagnosing sepsis - The role of laboratory medicine.Multi-marker approach using procalcitonin, presepsin, galectin-3, and soluble suppression of tumorigenicity 2 for the prediction of mortality in sepsis.Procalcitonin level as a surrogate for catheter-related blood stream infection among hemodialysis patients.
P2860
Combined biomarkers discriminate a low likelihood of bacterial infection among surgical intensive care unit patients with suspected sepsis.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Combined biomarkers discrimina ...... atients with suspected sepsis.
@en
type
label
Combined biomarkers discrimina ...... atients with suspected sepsis.
@en
prefLabel
Combined biomarkers discrimina ...... atients with suspected sepsis.
@en
P2093
P2860
P921
P1476
Combined biomarkers discrimina ...... atients with suspected sepsis.
@en
P2093
Barry D Fuchs
Brendan J Kelly
Centers for Disease Control and Prevention (CDC) Prevention Epicenters Program
Charles Garrigan
Ebbing Lautenbach
Irving Nachamkin
Jacqueleen Wise
Jeffrey S Gerber
Jennifer H Han
Pam Tolomeo
P2860
P304
P356
10.1016/J.DIAGMICROBIO.2016.01.003
P577
2016-01-08T00:00:00Z